Evidence map›Paper›PMID 36504978›Full record

ArticleFrontiers in public health2022

How the European Union legislations are tackling the burden of diabetes mellitus: A legal surveillance study.

Nour Mahrouseh, Szabolcs Lovas, Diana Wangeshi Njuguna, Noel Johny Nellamkuzhi, Carlos Alexandre Soares Andrade, Wilhelmina Egyirba Sackey, Anggi Septia Irawan, Orsolya Varga

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nour MahrousehDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Szabolcs LovasDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Diana Wangeshi NjugunaDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Noel Johny NellamkuzhiFaculty of Medicine, University of Debrecen, Debrecen, Hungary.
Carlos Alexandre Soares AndradeDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Wilhelmina Egyirba SackeyFaculty of Medicine, University of Debrecen, Debrecen, Hungary.
Anggi Septia IrawanDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Orsolya VargaDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
University of Debrecen · HUHungarian Research Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Surveillance of the European Union's (EU) legislations on the prevention of diabetes mellitus (DM) is needed, to more effectively tackle the rising prevalence of DM. Methods: This legal surveillance was carried out through a systematic search and screening, using EUR-Lex database to identify treaties, acts, and other legal documents for prevention of DM, non-communicable diseases (NCDs) and obesity, followed by their content analysis and assessment according to DM specific guidelines, target population and functional categories. Results and discussion: We found 22 legislations aimed at preventing DM, NCDs and obesity, but only 5 out of them specifically addressed preventing DM. The aims of legislations covered a broad spectrum of themes indicated by DM specific guidelines, mostly initiatives of life-course approach in preventing DM, NCDs and obesity from the area of energy intake. The target group of most legislations was the general population; high-risk subgroups such as pregnant women were hardly ever the primary target group. Our results prove that the EU has made cross-sectoral legislative efforts to reduce the disease burden and prevent DM but does not exhaust all possibilities. However, given its persistently rising DM prevalence, it is imperative to make sure that DM is a top health priority for various EU authorities and is incorporated into new initiatives, policies and laws.

Indexed as

Diabetes MellitusNoncommunicable DiseasesEuropean UnionFemaleHumansInternational CooperationObesityPregnancydiabetes mellitusEuropean Unionlegal mappingnon-communicable diseasesobesity

Identifiers

PMID36504978
PMCPMC9727193
OpenAlexW4309707539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.